Literature DB >> 28965776

Peripheral oxytocin and vasopressin are associated with clinical symptom severity and cognitive functioning in midlife women with chronic schizophrenia.

Leah H Rubin1, Heidi J Wehring2, Haley Demyanovich2, C Sue Carter3, Hossein Pournajafi-Nazarloo3, Stephanie M Feldman2, Amber K Earl2, Sharon August2, James M Gold2, Deanna L Kelly4.   

Abstract

Entities:  

Keywords:  Cognition; Hormones; Midlife women; Oxytocin; Schizophrenia

Mesh：

Substances：

Year:  2017        PMID： 28965776     DOI： 10.1016/j.schres.2017.09.041

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  10 in total

1.  Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia.

Authors:  Leah H Rubin; Siyi Li; Li Yao; Sarah K Keedy; James L Reilly; Scot K Hill; Jeffrey R Bishop; C Sue Carter; Hossein Pournajafi-Nazarloo; Lauren L Drogos; Elliot Gershon; Godfrey D Pearlson; Carol A Tamminga; Brett A Clementz; Matcheri S Keshavan; Su Lui; John A Sweeney
Journal:  Schizophr Res       Date:  2018-07-06       Impact factor: 4.939

2.  Endogenous oxytocin levels are associated with facial emotion recognition accuracy but not gaze behavior in individuals with schizophrenia.

Authors:  Michael J Spilka; William R Keller; Robert W Buchanan; James M Gold; James I Koenig; Gregory P Strauss
Journal:  Acta Psychiatr Scand       Date:  2022-03-16       Impact factor: 6.392

3.  The Role of OXT, OXTR, AVP, and AVPR1a Gene Expression in the Course of Schizophrenia.

Authors:  Marta Broniarczyk-Czarniak; Janusz Szemraj; Janusz Śmigielski; Piotr Gałecki
Journal:  Curr Issues Mol Biol       Date:  2022-01-12       Impact factor: 2.976

4.  Preliminary evidence that oxytocin does not improve mentalizing in women with schizophrenia.

Authors:  Ellen R Bradley; Marlene Tai; Michael Hankin; Joshua D Woolley
Journal:  Horm Behav       Date:  2020-12-28       Impact factor: 3.587

Review 5.  The Oxytocin-Vasopressin Pathway in the Context of Love and Fear.

Authors:  C Sue Carter
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-22       Impact factor: 5.555

6.  Posterior pituitary neurohormonal disturbances in schizophrenia and role of oxytocin in treatment - need for more short- and long-term studies.

Authors:  Owais Gul; Saqib Gul; Abdul Aziz Godil
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-05       Impact factor: 2.570

7.  Viral rescue of magnocellular vasopressin cells in adolescent Brattleboro rats ameliorates diabetes insipidus, but not the hypoaroused phenotype.

Authors:  K C Schatz; L M Brown; A R Barrett; L C Roth; V Grinevich; M J Paul
Journal:  Sci Rep       Date:  2019-06-03       Impact factor: 4.379

Review 8.  Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment.

Authors:  Kah Kheng Goh; Chun-Hsin Chen; Hsien-Yuan Lane
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

Review 9.  Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction.

Authors:  Kah Kheng Goh; Cynthia Yi-An Chen; Tzu-Hua Wu; Chun-Hsin Chen; Mong-Liang Lu
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

10.  Atrial natriuretic peptide and posterior pituitary neurohormone changes in patients with acute schizophrenia.

Authors:  Derya Guzel; Ahmet Bulent Yazici; Tugba Mutu Pek; Songul Doganay; Alime Burcin Saykan Simsek; Kadir Saglam; Caglar Turan; Esra Yazici
Journal:  Neuropsychiatr Dis Treat       Date:  2018-07-16       Impact factor: 2.570
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.